Documentos de Académico
Documentos de Profesional
Documentos de Cultura
Otero Regino Et Al., 2009 PDF
Otero Regino Et Al., 2009 PDF
William Otero Regino, MD,1 Alba Alicia Trespalacios, MSc,2 Elder Otero.3
Palabras clave
Helicobacter, triple terapia, levofloxacina, terapia secuencial, resistencia primaria.
Summary
Since when Helicobacter pylori was discovered, the eradication has been one of the most important cha-
llenges in gastroenterology. In many places, the prevalence of primary resistance of microorganism to the
different antibiotics is not known, and these are used empirically. In daily practice, no routine test is used to
verify the eradication, and therefore do not know the effectiveness of the schemes. Knowing these two factors
is possible identify those still infected and choose the next rescue therapy in a rational form. The absence of
information on pre-treatment resistance is a problem that cannot measure the impact of resistance to thera-
peutic failure. A global level, the standard triple therapy has lost the effectiveness that it had in the past and
sequential therapy is not equally effective everywhere, especially in regions where there is high resistance
to clarithromycin and metronidazole. The schemes have proved effective with levofloxacin triple therapies as
first line therapy or rescue, but it is necessary that each region takes its own schemes of treatment based on
susceptibility tests and pharmacogenomic studies.
Key words
Helicobacter, triple therapy, levofloxacin, sequential therapy, primary resistance.
Helicobacter pylori (H. pylori) es uno de los principales pató- desde el África oriental, con las cuales, este microorganismo
genos de la humanidad, con la cual ha mantenido una estre- fue diseminado hacia otras regiones del mundo (1, 2). A
cha relación desde hace aproximadamente 58.000 años, pesar de esta convivencia desde la prehistoria, H. pylori solo
mucho antes de que se iniciaran las migraciones humanas fue reconocido como patógeno hace un poco más de 25